165 results
Page 5 of 9
8-K
EX-10.1
v4g8vz47f9xfjdn
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.2
wf3d2l
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.1
ub68bvm8mtmt uoa3u2
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.1
jccszq5fgs 49t
8 Jan 21
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
l68tn ezzn277sj17v9
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-2.1
if3inadzyl4ocw us
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-99.1
y3o5v62 q5y91
2 Sep 20
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
8:57am
8-K
EX-99.1
n2ajc2
26 May 20
NeuroBo Pharmaceuticals Announces Continuation of Partial
8:39am
424B5
f0khwxv4
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-10.1
ajldmz vv7prf9is8
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-99.1
si7 772cre5
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-99.1
yzn5hqbtonho4up
30 Mar 20
NeuroBo Pharmaceuticals Reports Year End 2019 Financial Results and Provides Corporate Strategic Update
5:23pm
8-K
EX-10.1
7x2pw48r903anua
13 Feb 20
Departure of Directors or Certain Officers
4:01pm